CARLOMAGNO, C., DANIELE, G., BIANCO, R., MARCIANO, R., DAMIANO, V., MATANO, E., . . . TORTORA, G. (2011). Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials. D.A. Spandidos.
Chicago Style CitationCARLOMAGNO, CHIARA, et al. Addition of Erlotinib to Fluoropyrimidine-oxaliplatin-based Chemotherapy With or Without Bevacizumab: Two Sequential Phase I Trials. D.A. Spandidos, 2011.
Cita MLACARLOMAGNO, CHIARA, et al. Addition of Erlotinib to Fluoropyrimidine-oxaliplatin-based Chemotherapy With or Without Bevacizumab: Two Sequential Phase I Trials. D.A. Spandidos, 2011.
Atenció: Aquestes cites poden no estar 100% correctes.